15-70687977-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_018003.4(UACA):c.425-157A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 152,178 control chromosomes in the GnomAD database, including 1,488 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.13   (  1488   hom.,  cov: 32) 
Consequence
 UACA
NM_018003.4 intron
NM_018003.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.588  
Publications
3 publications found 
Genes affected
 UACA  (HGNC:15947):  (uveal autoantigen with coiled-coil domains and ankyrin repeats) This gene encodes a protein that contains ankyrin repeats and coiled coil domains and likely plays a role in apoptosis. Studies in rodents have implicated the encoded protein in the stimulation of apoptosis and the regulation of mammary gland involution, in which the mammary gland returns to its pre-pregnant state. This protein has also been proposed to negatively regulate apoptosis based on experiments in human cell lines in which the protein was shown to interact with PRKC apoptosis WT1 regulator protein, also known as PAR-4, and inhibit translocation of the PAR-4 receptor. Autoantibodies to this protein have been identified in human patients with panuveitis and Graves' disease. Differential expression of this gene has been observed in various human cancers. [provided by RefSeq, May 2017] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.201  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.129  AC: 19663AN: 152060Hom.:  1486  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
19663
AN: 
152060
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.129  AC: 19675AN: 152178Hom.:  1488  Cov.: 32 AF XY:  0.127  AC XY: 9475AN XY: 74392 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
19675
AN: 
152178
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
9475
AN XY: 
74392
show subpopulations 
African (AFR) 
 AF: 
AC: 
8497
AN: 
41504
American (AMR) 
 AF: 
AC: 
1425
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
458
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
413
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
695
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
1178
AN: 
10596
Middle Eastern (MID) 
 AF: 
AC: 
39
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
6686
AN: 
67998
Other (OTH) 
 AF: 
AC: 
242
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 831 
 1661 
 2492 
 3322 
 4153 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 214 
 428 
 642 
 856 
 1070 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
388
AN: 
3476
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 DS_AG_spliceai 
Position offset: 0
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.